Pharmadrug Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was CAD 5.38 million compared to CAD 1.15 million a year ago. Basic loss per share from continuing operations was CAD 0.002 compared to CAD 0.002 a year ago.
For the six months, sales was CAD 0.000864 million compared to CAD 0.001255 million a year ago. Net loss was CAD 7.44 million compared to CAD 2.88 million a year ago. Basic loss per share from continuing operations was CAD 0.007 compared to CAD 0.007 a year ago.